AERAMI

Aerami Therapeutics is a clinical stage biopharmaceutical company engaged in the development of differentiated inhaled therapies for the treatment of cardiopulmonary conditions... At Aerami Therapeutics, we leverage our proprietary inhalation technology to develop differentiated inhaled therapies for the treatment of cardiopulmonary conditions... Each of our current product candidates is based on targeted molecules with promising clinical or preclinical track records and/or data sets within targeted indications, enabling focused and efficient development plans. We aim to combine these therapies with advanced administration platforms to develop differentiated medicines with the goal of extending and improving patients' lives, preventing disease development or progression.

Also known as: Aerami Therapeutics, Aerami Therapeutics Holdings, Aerami Therapeutics Holdings, Inc.

Primary location: Durham United States